Sarah A. Scuderi

Messina, 98166, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

RETRACTED: Scuderi et al. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. Int. J. Mol. Sci. 2022, 23, 2269.

RETRACTED: Scuderi et al. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. Int. J. Mol. Sci. 2022, 23, 2269.

Journal: International journal of molecular sciences

Published: May 19, 2026

The promising role of cathepsins as biomarkers and therapeutic targets in glioblastoma.

The promising role of cathepsins as biomarkers and therapeutic targets in glioblastoma.

Journal: Discover oncology

Published: January 25, 2026

Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice.

Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice.

Journal: Methods in cell biology

Published: September 10, 2025

Modulation of Wnt/β-Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells.

Modulation of Wnt/β-Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells.

Journal: Journal of cellular and molecular medicine

Published: September 01, 2025

Aesculus hippocastanum Extract Exerts Neuroprotective Effects in an MPP+-Induced Parkinson's Disease Model via PPARγ Activation.

Aesculus hippocastanum Extract Exerts Neuroprotective Effects in an MPP+-Induced Parkinson's Disease Model via PPARγ Activation.

Journal: Journal of cellular and molecular medicine

Published: August 18, 2025

The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.

The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.

Journal: Biomedicines

Published: July 24, 2025

Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells.

Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells.

Journal: Experimental eye research

Published: July 09, 2025

Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models.

Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models.

Journal: Journal of cellular and molecular medicine

Published: May 23, 2025

An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies.

An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies.

Journal: Brain sciences

Published: May 14, 2025

Targeting enhancer of zeste homolog 2: A novel therapeutic approach for head and neck cancer.

Targeting enhancer of zeste homolog 2: A novel therapeutic approach for head and neck cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 17, 2025

PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models.

PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models.

Journal: Biomolecules

Published: March 29, 2025

Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.

Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.

Journal: Cell reports. Medicine

Published: March 21, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026